Green Thumb Industries (GTII) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
16 Jun, 2026Market landscape and growth outlook
U.S. cannabis market projected to reach $100B by 2030, rivaling alcohol and tobacco industries in size.
Cannabis industry expected to grow at a 12% CAGR through 2027, outpacing beer, tobacco, spirits, and wine.
Federal policy momentum includes medical rescheduling and new pathways for state-licensed operators, with adult-use review ongoing.
Majority of Americans (64%) support legalization, driving expansion of state programs and access.
Legal cannabis generates more tax revenue than alcohol in established markets and supports over 440,000 jobs.
Company overview and strategy
Operates 110+ retail stores across 14 states, serving half of U.S. adults, with 20 manufacturing facilities.
Focused on high-demand, limited-supply markets, building trusted brands, and disciplined capital allocation.
Portfolio includes leading brands across flower, vape, edibles, pre-rolls, beverages, and concentrates.
Omni-channel retail strategy integrates digital, delivery, and in-store experiences, with 1.7M+ loyalty members.
Committed to restorative justice, community engagement, inclusion, and environmental stewardship.
Financial performance and structure
Q1 2026 revenue grew 7% YoY to $300M, with normalized EBITDA margin above 31%.
2025 annual revenue reached $1.175B, with consistent EBITDA and cash flow growth over recent years.
Strong balance sheet with $344.5M in cash and $289.9M in debt as of March 31, 2026.
Share structure includes 225.9M basic shares and 242.5M fully diluted shares outstanding.
Non-GAAP metrics such as normalized EBITDA are used to supplement GAAP results.
Latest events from Green Thumb Industries
- Market leader in THC with strong brands, financials, and growth from regulatory tailwinds.GTII
Investor presentation - Q2 revenue up 5% to $307M, strong cash flow, and robust share buybacks amid regulatory progress.GTII
Q2 2026 - All proposals passed, with strong financials and strategic focus on regulatory and brand growth.GTII
AGM 2026 - Cannabis market growth and brand leadership drive robust revenue and EBITDA performance.GTII
Investor presentation - Q1 2026 revenue up 7.5% to $300.2M, strong cash flow, and expanded share buybacks.GTII
Q1 2026 - Revenue rose 3.4% in 2025, with strong cash flow and retail expansion offset by margin pressure.GTII
Q4 2025 - Q2 revenue up 4.7% to $293.3M, but margins pressured by price compression and regulatory headwinds.GTII
Q2 2025 - Q3 revenue up 4% to $287M, Adjusted EBITDA margin 31.1%, strong cash flow and liquidity.GTII
Q3 2024 - Revenue up 1.4% to $280M, but net income and margins declined amid price compression.GTII
Q1 2025